Quetiapine Augmentation in Severe Obsessive Compulsive Disorder
NCT00254735
·
clinicaltrials.gov ↗
PHASE3
Phase
COMPLETED
Status
44
Enrollment
INDUSTRY
Sponsor class
Conditions
Obsessive Compulsive Disorder
Interventions
DRUG:
quetiapine fumarate
DRUG:
SSRI/Clomipramine
Sponsor
AstraZeneca